Company / Working Capital per Share
Emergent BioSolutions Inc. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$10.18
FY2025
5-year range
-$0.36 / $17.51
FY2021-FY2025
Trend
+26.7%
vs FY2024
Sector context
#48 of 210
Health Care
What the data says
Emergent BioSolutions Inc.'s working capital per share of $10.18 is higher than 77% of companies in the Health Care sector (FY2025). Working Capital per Share has increased for 3 consecutive years, from $-0.36 in FY2022 to $10.18 in FY2025.
Based on SEC 10-K filings.
10.18 in FY2025 with a 5-year CAGR of -8.3%. Top quartile in the Health Care sector.
Improved from $0.54 to $10.18 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -8.3%
- 10-Year CAGR
- -
Sector benchmark
-93.1% below sector average
Key checks
Key Insights
- Emergent BioSolutions Inc.'s working capital per share has grown for 3 consecutive years.
- In FY2025, working capital per share increased 26.7% year-over-year.
- Ranks #48 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.18 | +26.7% |
| FY2024 | $8.03 | +1387.3% |
| FY2023 | $0.54 | +249.8% |
| FY2022 | -$0.36 | -102.1% |
| FY2021 | $17.51 | +11.6% |
| FY2020 | $15.69 | +72.7% |
| FY2019 | $9.09 | +6.8% |
| FY2018 | $8.51 | -10.4% |
| FY2017 | $9.50 | -7.5% |
| FY2016 | $10.26 | -11.6% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026